Transcranial Magnetic Stimulation (TMS) Therapy

CARMAhealth Offers Next-Level Transcranial Magnetic Stimulation (TMS) Therapy for Depression and Additional Behavioral Health Issues

Up to 60% of individuals with an alcohol use disorder and depression continue to suffer from depression even after they have stopped drinking. TMS offers a safe and effective therapy for individuals for whom medications for depression have failed.

Deep TMS Therapy at CARMAhealth

CARMAhealth and BrainsWay offer a more targeted and in-depth form of TMS therapy, and are pleased to offer our clients the highest form of the practice. Traditional TMS coils are rigid, eight-point instruments that offer limited flexibility. BrainWay’s Deep TMS H-Coils offer a more flexible design that allows the coil to conform to the curvature of the scalp for maximum magnetic coupling. The design allows the coils to act more cooperatively to form a deeper and broader electric field with a much slower rate of decay. Deep TMS is a safe, proven and effective therapy that may be a viable resource for you or your loved one.

If you have any additional questions, please don’t hesitate to contact your CARMAhealth provider or email our staff at tms@carmahealth.com

Our Services

TMS Therapy Testimonials

Transcranial magnetic stimulation (TMS) has been a very exciting treatment for the last 20 years and it’s only becoming more intriguing that we understand its potential to treat an myriad of psychiatric conditions. It has been most widely studied and utilized for treatment resistant depression (TRD), but as our knowledge of the technology grows, there is potential to treat anxiety disorders, substance use disorders, and other medical conditions. It is a non-invasive, evidence supported treatment for depression when medications have fallen short, not sufficient or contraindicated.

New data has shown that the number of treatment sessions to an effect maybe as little as 20 sessions to achieve significant relief in depressive symptoms. And new evidence supports reason to believe that TMS may be a promising treatment for all age groups with TRD.  A study examining treatment response in teens with mean age of 16.4 years old showed effects were tolerable and associated with clinical improvement. On the opposite end, patients later in life also show response to TMS. In a study published in January 2024, TMS was shown to have significant response rates with patients age 60-91.

Some patients may find further benefit with combining Ketamine treatments along with TMS to further target their depressive symptoms. The evidence suggest that these two treatments in combination can potentially offer rapid relief from depression. We are proud to offer both treatments to our patients at CARMAhealth.